Am J Health Syst Pharm. 2007;64(21):2227-2236. A recent study found an increased incidence of CHF in older women who had more than 10 years of follow-up and were treated with adjuvant anthracyclines. ...

Zyprexa addition to standard antiemetics significantly reduces RINV incidence and severity in abdominal/pelvic radiotherapy patients. The trial showed marked improvements in nausea, vomiting, anxiety, ...

In this small breast cancer–dedicated solo practice, a retrospective medical record review disclosed the following: significant rate of chemotherapy-related nausea and vomiting and discordance between ...

Alternative End Points to Evaluate a Therapeutic Strategy in Advanced Colorectal Cancer: Evaluation of Progression-Free Survival, Duration of Disease Control, and Time to Failure of Strategy—An Aide ...

Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus ...

Adding cannabis extract to standard antiemetics tripled the rate of complete response for treatment-refractory chemotherapy-induced nausea and vomiting (CINV), a randomized trial showed. The complete ...

ASCO releases guidelines for antiemetics in oncology The updated guidelines will help clinicians prevent and manage nausea and vomiting caused by antineoplastic agents or radiation therapy in cancer ...

Researchers from Japan found that a 5 mg dose of olanzapine, taken after chemotherapy, significantly reduces nausea and vomiting in breast cancer patients, while minimizing sedation and cutting costs.